Marta N.
- Country
- Norway
- Department
- Dept of Oncology
Research Overview
- Evaluation of Belvarafenib Monotherapy and Combination Therapy with Cobimetinib and Nivolumab in NRAS-Mutant Advanced Cutaneous Melanoma Patients
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
- A Phase 2 Study of Intratumoral Injection of LTX-315 in Combination with Pembrolizumab in Patients with Percutaneously Accessible Lesions with Advanced Melanoma Refractory to PD-1/PD-L1 Inhibitor Therapy
Data & Insights
Has run more than one trial at 52 of 262 partner sites.
Specializations
Melanoma Research
Specializes in investigating novel treatment approaches for advanced melanoma, with particular emphasis on NRAS-mutant melanoma variants. The investigator focuses on therapeutic strategies for patients who have developed resistance to conventional treatments.
- Advanced cutaneous melanoma treatment
- NRAS mutation-targeted therapies
- Melanoma resistance mechanisms
Explores innovative combination approaches including targeted therapies and immunotherapy agents.
Immunotherapy Innovation
Conducts research in immune checkpoint inhibition, specifically investigating novel combinations with anti-LAG-3 and anti-PD-1 therapies. Focuses on developing more effective immunotherapy strategies for cancer treatment.
- Checkpoint inhibitor combinations
- Novel immunotherapy approaches
- Treatment-resistant cancers
Evaluates innovative dosing regimens to optimize therapeutic outcomes in cancer treatment.
Solid Tumor Therapeutics
Investigates treatment solutions for various advanced solid tumors, with expertise in developing and evaluating combination therapeutic strategies. Focuses on enhancing treatment responses through targeted approaches.
- Advanced tumor treatment
- Combination therapy development
- Treatment optimization strategies
Studies the clinical benefits of various therapeutic combinations in solid tumor treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.